Benitec Biopharma Limited
BNTCW
BNTCW was delisted on the 14th of April, 2020.
2 hedge funds and large institutions have $52K invested in Benitec Biopharma Limited in 2017 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
247% more capital invested
Capital invested by funds: $15K → $52K (+$37K)
33% less funds holding
Funds holding: 3 → 2 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$9.35K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $37K | +$9.35K | +27,017 | +28% |
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $15K | – | – | – |
|
BNTCW Hedge Fund Activity: Q1 2017 in Review
2 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Benitec Biopharma Limited (BNTCW) for Q1 2017, worth a combined $52K — up 247% from $15K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BNTCW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was Sabby Management, adding an estimated $9.35K.
- 2 institutional investors held Benitec Biopharma Limited (BNTCW) as of Q1 2017, down from 3 in Q4 2016.
- Funds reported $52K of Benitec Biopharma Limited stock for Q1 2017, up 247% quarter-over-quarter.
- 0 funds opened new Benitec Biopharma Limited positions in Q1 2017 and 1 closed out, a net change of -1 holder.
- The largest Benitec Biopharma Limited buyer in Q1 2017 was Sabby Management, an estimated $9.35K added.
Based on aggregated 13F filings for Q1 2017.